Antibody drug conjugates (ADCs) are an exciting and challenging new area of research and are becoming ever more popular across the industry with more than 100 ADCs reported in the clinic. The targeted nature of the molecules makes them extremely suitable for delivering toxic molecules to the biological target.
However the complexity of the molecules and the lack of regulatory experience increases the complexity in discovery and development across all disciplines.
This symposium brings together experts from across the industry to share their knowledge and learning for an engaging and exciting meeting.
Speakers:
Dr Stuart Dunn - Labcorp
Dr Richard Easton - BioPharmaSpec
Dr Colin McKee - Sterling Pharma
Dr Christiane Niederlaender - Parexel
Prof Miraz Rahman - Kings College London
Dr Gary Watts - Abzena
EVENT LINK: https://www.jpag.org/154
VENUE LINK: www.rsc.org/locations-contacts/
WEB LINK: https://www.jpag.org/
ORGANISED BY: Joint Pharmaceutical Analysis Group
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
Comments